Immunic (IMUX) Earnings Date & Reports

Industry: @Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

IMUX is expected to report earnings to fall 1.79% to -23 cents per share on February 20

Q4'24

Est.

$-0.24

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.02

Q1'24

Missed

by $0.04

Q4'23

Beat

by $0.03

The last earnings report on November 07 showed earnings per share of -23 cents, missing the estimate of -21 cents. With 338.40K shares outstanding, the current market capitalization sits at 96.38M.

View a ticker or compare two or three

Compare

IMUX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IMUX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of pharmaceuticals and oral therapies for the treatment of chronic inflammatory and autoimmune diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

1200 Avenue of the Americas

Phone

+1 332 255-9818

Employees

Web

https://www.imux.com